Lisa M Sclafani

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Training a new generation of breast surgeons: are we succeeding?
    Lisa M Sclafani
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:1856-61. 2012
  2. ncbi Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction
    Lisa M Sclafani
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York 10065, USA
    Cancer J 14:216-22. 2008
  3. ncbi Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy
    Sarah A McLaughlin
    Department of Breast Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:76-82. 2008
  4. ncbi Is pleomorphic lobular carcinoma really a distinct clinical entity?
    Claire L Buchanan
    Department of Surgery, Swedish Cancer Institute, Seattle, Washington, USA
    J Surg Oncol 98:314-7. 2008
  5. ncbi Locoregional recurrence after mastectomy: incidence and outcomes
    Claire L Buchanan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Coll Surg 203:469-74. 2006
  6. ncbi Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
    Jane E Mendez
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, New York 10021, USA
    Ann Surg Oncol 12:24-8. 2005

Collaborators

Detail Information

Publications6

  1. ncbi Training a new generation of breast surgeons: are we succeeding?
    Lisa M Sclafani
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:1856-61. 2012
    ..Society of Surgical Oncology (SSO)-approved fellowships in Breast Oncology began training fellows in 2004. Here we ascertain methods of evaluating and improving the fellowship experience through fellowship alumni experience...
  2. ncbi Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction
    Lisa M Sclafani
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York 10065, USA
    Cancer J 14:216-22. 2008
    ..The incidence and etiology of these complications are investigated as are the risk factors, and methods of prevention and treatment. Recommendations for avoiding these morbidities for postoperative rehabilitation are discussed...
  3. ncbi Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy
    Sarah A McLaughlin
    Department of Breast Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:76-82. 2008
    ..The purpose of this study was to determine if eliminating FS would change reoperation rates in BCT patients...
  4. ncbi Is pleomorphic lobular carcinoma really a distinct clinical entity?
    Claire L Buchanan
    Department of Surgery, Swedish Cancer Institute, Seattle, Washington, USA
    J Surg Oncol 98:314-7. 2008
    ..We describe our experience with PLC as compared to classic ILC and invasive ductal carcinoma (IDC)...
  5. ncbi Locoregional recurrence after mastectomy: incidence and outcomes
    Claire L Buchanan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Coll Surg 203:469-74. 2006
    ..But for patients presenting with LRR without evidence of distant disease, aggressive multimodality therapy is warranted because many of these patients can be rendered disease free...
  6. ncbi Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
    Jane E Mendez
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, New York 10021, USA
    Ann Surg Oncol 12:24-8. 2005
    ..We undertook this study to determine whether SLNB could be omitted in clinically node-negative patients with favorable-histology breast cancer...